Cargando…
Antigen presentation of the Oct4 and Sox2 peptides by CD154-activated B lymphocytes enhances the killing effect of cytotoxic T lymphocytes on tumor stem-like cells derived from cisplatin-resistant lung cancer cells
The present study investigated whether antigen presentation of the Oct4 and Sox2 peptides by CD154-activated B lymphocytes can enhance the killing effect of CD8(+) cytotoxic T lymphocytes (CTLs) on lung stem-like cancer cells (SLCCs). The CTLs were generated using an accelerated co-cultured dendriti...
Autores principales: | Zhang, Xueyan, Zhang, Yanwei, Xu, Jianlin, Wang, Huimin, Zheng, Xiaoxuan, Lou, Yuqing, Han, Baohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771344/ https://www.ncbi.nlm.nih.gov/pubmed/29344283 http://dx.doi.org/10.7150/jca.20821 |
Ejemplares similares
-
Comparison of outcomes of tyrosine kinase inhibitor in first- or second-line therapy for advanced non-small-cell lung cancer patients with sensitive EGFR mutations
por: Xu, Jianlin, et al.
Publicado: (2016) -
The Kinematics of Cytotoxic Lymphocytes Influence Their Ability to Kill Target Cells
por: Bhat, Purnima, et al.
Publicado: (2014) -
Wnt blockers inhibit the proliferation of lung cancer stem cells
por: Zhang, Xueyan, et al.
Publicado: (2015) -
Cyclooxygenase 2 Modulates Killing of Cytotoxic T Lymphocytes by Colon Cancer Cells
por: Wang, Quanxin, et al.
Publicado: (2009) -
Correction: The Kinematics of Cytotoxic Lymphocytes Influence Their Ability to Kill Target Cells
Publicado: (2014)